Template:Imipenem cilastatin: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | style="padding: 0 5px; font-size: 100%; background:#6969..."
 
Gerald Chi (talk | contribs)
mNo edit summary
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
| style="padding: 0 5px; font-size: 100%; background:#696969" align=center | <span style="color:WHITE;"> '''[[Imipenem cilastatin]]'''</span>
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Imipenem cilastatin|{{fontcolor|#6C7B8B|Imipenem Cilastatin}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:WHITE" align=left | FDA Package Insert (Unasyn®)
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | PRIMAXIN<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin description|Description]]
Line 14: Line 14:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin warnings|Warnings]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin warnings and precautions|Warnings and Precautions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin precautions|Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin adverse reactions|Adverse Reactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin dosage and administration|Dosage and Administration]]
Line 31: Line 27:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin how supplied|How Supplied]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin how supplied|How Supplied]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin other size packages available|Other Size Packages Available]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Imipenem cilastatin labels and packages|Labels and Packages]]
|-
|-
|}
|}

Latest revision as of 22:25, 5 January 2014